TB-500: Thymosin Beta-4 for Tissue Repair
Evidence-based review of TB-500 peptide for tissue repair and wound healing. Mechanisms, research status, dosing, and clinical perspective from Dr. Julian Douwe
Peptide Therapy
Limited EvidenceThymosin beta-4 fragment with no published human trials. What the full-length protein studies show, risks and regulatory status.
Evidence-based review of TB-500 peptide for tissue repair and wound healing. Mechanisms, research status, dosing, and clinical perspective from Dr. Julian Douwe
GLOW is a vendor blend, usually GHK-Cu 50 mg, BPC-157 10 mg and TB-500 10 mg. What each part does, the untested combination, quality data and protocols.
KLOW is a vendor blend of GHK-Cu 50 mg, BPC-157, TB-500 and KPV 10 mg each. Components, the missing combination data, lab-test results and protocols.
Tri-Heal Max is a 45 mg vendor blend of TB-500 25 mg, BPC-157 10 mg and KPV 10 mg. What it contains, why protocols disagree, and what is unknown.
Evidence-based cycling schedules for BPC-157, TB-500, CJC-1295/Ipamorelin, Sermorelin, Epithalon, and Thymosin Alpha-1 — when to run, when to pause, and why it matters.
Thymosin Beta-4 (TB-500) promotes cardiac regeneration after ischemic injury. A physician-written guide to the research, mechanisms, dosing considerations, and who this may benefit.
What FDA's May 2026 503A category update actually changed for peptides: GHK-Cu, VIP, the withdrawn category 2 nominations, and what it means for US access.
Dr. Douwes reviews the evidence for peptide-based hair loss therapy — GHK-Cu, TB-500, KGF, and PTD-DBM — with dosing, mechanisms, and realistic expectations.
Learn how to combine therapeutic peptides like BPC-157, TB-500, and GHK-Cu, with dosing protocols, the clinical evidence, and the safety questions.
Dr. Douwes reviews the clinically relevant benefits of peptide therapy — from tissue repair and immune modulation to longevity and brain health. What evidence supports each claim.
Dr. med. univ. Julian Douwes ranks the most effective peptides for tissue repair, wound healing, and recovery — with dosing context and evidence grades for each.
Evidence-based TB-500 dosing protocols. Loading and maintenance phases, injection frequency, cycling schedules, and clinical dosing rationale.
How TB-500 supports tendon and ligament healing. Mechanisms, preclinical evidence, clinical observations, and practical protocols for connective tissue.
A clinical comparison of BPC-157 and TB-500 for tissue repair. Mechanisms, evidence quality, best use cases, combination protocols, and what is seen in practice.
Honest assessment of TB-500 side effects, WADA ban context, theoretical risks, and what clinical experience shows about Thymosin Beta-4 safety.